6505--Metolazone Tablets (VA-26-00032237)

The Department of Veterans Affairs National Acquisition Center plans to issue a Request for Proposal (RFP) for the procurement of Metolazone Tablets to serve the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. This contract will be awarded to a single responsible offeror who can guarantee a continuous supply of the medication. The base contract period is one year, with four additional one-year option periods at pre-established prices. Distribution will occur through the Pharmaceutical Prime Vendor Programs of the VA and DOD. Offerors must provide the exact product name as labeled, along with a unique NDC number, and packaging in glass bottles is prohibited. The solicitation will be released electronically around April 1, 2026, with a closing date around April 14, 2026, and all related documents will be accessible exclusively via the official federal procurement website. The estimated annual demand for Metolazone Tablets includes 700 bottles of 10 mg size, 7,649 bottles of 2.5 mg size, and 6,614 bottles of 5 mg size, each packaged in bottles of 100 tablets. The solicitation follows commercial item procurement procedures under FAR Part 12 and is classified under NAICS code 325412. Interested parties are encouraged to monitor the procurement site regularly for updates and amendments. The designated point of contact for inquiries is Amber Zavala, who can be reached by email or phone for additional information. This effort aims to ensure a reliable supply of this essential medication across multiple federal healthcare programs.